Literature DB >> 10665570

Surveillance after colorectal cancer resection.

J M Berman1, R J Cheung, D S Weinberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10665570     DOI： 10.1016/S0140-6736(99)06552-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

1.  Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

Authors:  Ulrich Guller; Paul Zajac; Annelies Schnider; Beatrix Bösch; Stefan Vorburger; Markus Zuber; Giulio Cesare Spagnoli; Daniel Oertli; Robert Maurer; Urs Metzger; Felix Harder; Michael Heberer; Walter Richard Marti
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

2.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Hiroya Takiuchi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2011-10-15       Impact factor: 3.402

3.  The serum level of carcinoembryonic antigen in drainage venous blood is not a sensitive predictor of metachronous hepatic metastasis for patients with colorectal cancer.

Authors:  Masashi Haraguchi; Fumihiko Fujita; Yasuhiro Torashima; Takamitsu Inokuma; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

4.  Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.

Authors:  Jong Wan Kim; Hyun Chul Kim; Ji Won Park; Sung Chan Park; Dae Kyung Sohn; Hyo Seong Choi; Dae Yong Kim; Hee Jin Chang; Ji Yeon Baek; Sun Young Kim; Seok Ki Kim; Jae Hwan Oh
Journal:  Int J Colorectal Dis       Date:  2013-02-13       Impact factor: 2.571

5.  Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.

Authors:  Jocelyn Bellier; Julien De Wolf; Mohamed Hebbar; Mehdi El Amrani; Christophe Desauw; Emmanuelle Leteurtre; François-René Pruvot; Henri Porte; Stéphanie Truant
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

6.  [Present treatment strategies for rectal carcinoma].

Authors:  T Liersch; C Langer; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

7.  Dynamic Optimal Strategy for Monitoring Disease Recurrence.

Authors:  Hong Li; Constantine Gatsonis
Journal:  Sci China Math       Date:  2012-08-01       Impact factor: 1.331

8.  Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.

Authors:  Mi Joo Chung; Taek Keun Nam; Jae Uk Jeong; Sung Hwan Kim; Kyubo Kim; Hong Seok Jang; Bae Kwon Jeong; Jong Hoon Lee
Journal:  Int J Colorectal Dis       Date:  2016-07-28       Impact factor: 2.571

9.  Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey.

Authors:  Erica S Breslau; Diana D Jeffery; William W Davis; Richard P Moser; Timothy S McNeel; Sarah Hawley
Journal:  J Cancer Surviv       Date:  2009-11-02       Impact factor: 4.442

10.  Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence.

Authors:  Harald Hoensch; Bertram Groh; Lutz Edler; Wilhelm Kirch
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.